Acknowledgements
The authors would like to thank the volunteers who participated in the phase 2 trial described herein. The studies in this report were supported by 89bio, Inc. We thank Antaros Medical for providing MRI-PDFF images, J. Eastman, Dennig Marketing Group, for data table and figure creation, and D. Norris Ph.D., Ecosse Medical Communications, LLC, for writing assistance (the first draft of the manuscript was written by D.L.B.).